Company Monitoring Page for Amgen

latest headlines for company on cafepharma

Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme
Fierce Pharma
Wed, 06/1/22 - 07:36 pm
Tags:
Regeneron, Amgen, FDA, antitrust, legal, Repatha, Praluent
Amgen eyes swift move to ph3 for cardiovascular drug olpasiran
Pharmaforum
Wed, 06/1/22 - 09:33 am
Tags:
Amgen, olpasiran, Novartis, clinical trials, cardiovascular disease
Amneal scores third biosimilar approval in three months
Biopharma Reporter
Tue, 05/31/22 - 10:31 am
Tags:
Amneal, FDA, biosimilars, pegfilgrastim, Fylnetra, Amgen, Neulasta
Mirati matches Amgen with updated data for KRAS-blocking cancer drug
BioPharma Dive
Fri, 05/27/22 - 10:15 am
Tags:
Mirati Therapeutics, Amgen, KRAS, adagrasib, Lumakras, clinical trials
Bristol's Abecma, Amgen's Lumakras headline record-setting oncology launch class as costs continue to balloon: IQVIA
Fierce Pharma
Thu, 05/26/22 - 10:53 pm
Tags:
oncology, cancer, IQVIA, Bristol Myers Squibb, Abecma, Amgen, Lumakras
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?
Motley Fool
Mon, 05/23/22 - 06:44 pm
Tags:
Amgen, biosimilars, Stelara, JNJ
Amgen celebrates 25 years of deCODE Genetics as partnership evolves from discovery to development
Fierce Biotech
Fri, 05/20/22 - 10:16 am
Tags:
Amgen, M&A, deCODE Genetics, drug discovery, drug development
Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data
Fierce Biotech
Thu, 05/12/22 - 10:48 am
Tags:
Bristol Myers Squibb, deucravacitinib, clinical trials, psoriasis, Amgen, Otezla
The 12 Top Biotech Companies Hiring Now
BioSpace
Tue, 05/10/22 - 10:26 pm
Tags:
biotech, life sciences, hirings, Regeneron, Pfizer, Amgen, AbbVie, Moderna Therapeutics, CSL Behring, Waters Corporation, Daiichi Sankyo, Gilead Sciences, Grail, Emergent BioSolutions, resilience
Amgen spinout Kezar hits PhII hurdle, all eyes on June readout for drug’s other study
Endpoints
Wed, 05/4/22 - 10:39 am
Tags:
Amgen, Kezar Life Sciences, zetomipzomib, autoimmune disease, dermatomyositis, polymyositis
Amgen Battles IRS Over Billions in "Wholly Unwarranted" Tax Penalties
BioSpace
Wed, 04/27/22 - 10:47 pm
Tags:
Amgen, earnings, taxes, IRS
A bad day for Molecular Partners
EP Vantage
Wed, 04/27/22 - 10:45 am
Tags:
Molecular Partners, MP0310, Amgen, Novartis, ensovibep
Thought CETP inhibition was dead? Think again
EP Vantage
Sat, 04/23/22 - 04:17 pm
Tags:
New Amsterdam, Amgen, CETP inhibitors, obicetrapib
Amgen parts ways with part of Ventura County headquarters campus: report
Fierce Pharma
Thu, 04/14/22 - 10:44 am
Tags:
Amgen, California, headquarters
Novartis Highlights Early Data from Potential Lumakras Competitor at AACR
BioSpace
Tue, 04/12/22 - 10:49 am
Tags:
Novartis, AACR, JDQ443, clinical trials, Amgen, Lumakras
AACR: 2 years in, Amgen fortifies Lumakras lung cancer data fortress for upcoming Mirati, Novartis KRAS battle
Fierce Pharma
Sun, 04/10/22 - 07:46 pm
Tags:
AACR, Amgen, Lumakras, Mirati Therapeutics
ACC 2022 – Astra’s cholesterol lowerer surprise comes just a little late
EP Vantage
Tue, 04/5/22 - 10:59 am
Tags:
AstraZeneca, Ionis Pharmaceuticals, AZD8233, cholesterol, ACC, Amgen, Sanofi, Novartis, Regeneron
As Eli Lilly grows beyond Research Triangle Park, biopharmas big and small are tapping North Carolina's 'limitless' potential
Fierce Pharma
Tue, 03/8/22 - 10:22 am
Tags:
North Carolina, RTP, Eli Lilly, Amgen, Jaguar Gene Therapy, Thermo Fisher, biotech, biotech hubs
Plexium nabs $102M for protein degradation work weeks after $500M Amgen tie-up
Fierce Biotech
Wed, 02/23/22 - 10:34 am
Tags:
Plexium, Amgen, protein degradation, venture capital, funding
Innovent's phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market
Fierce Biotech
Thu, 02/17/22 - 10:56 am
Tags:
Innovent Biologics, China, clinical trials, Amgen, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.